Dr Adetokunbo Olusola Ladipo, MD | |
1306 Leighton Ave., Anniston, AL 36207 | |
(256) 236-3031 | |
(256) 236-3202 |
Full Name | Dr Adetokunbo Olusola Ladipo |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 34 Years |
Location | 1306 Leighton Ave., Anniston, Alabama |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972601607 | NPI | - | NPPES |
109509 | Medicaid | AL | |
1417168485 | Other | AL | OMNI CLINIC GROUP NPI |
1326259300 | Other | AL | OMNI CLINIC OF SLYACAUGA |
009938730 | Medicaid | AL | |
051517112 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 23571 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Northeast Alabama Regional Medical Center | Anniston, AL | Hospital |
Entity Name | Lhm Clinic, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093959843 PECOS PAC ID: 8325193113 Enrollment ID: O20090831000381 |
News Archive
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that it has reached the enrollment goal of 325 patients for its Phase 2b dose-ranging clinical trial of XOMA 052, and that it expects patient enrollment to close in July 2010, with top-line results available in the first quarter of 2011. XOMA 052 is a therapeutic antibody candidate that inhibits the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) which drives the inflammatory cause of Type 2 diabetes.
Transcept Pharmaceuticals, Inc. today announced that it has completed enrollment in its Phase 2 clinical trial evaluating TO-2061 added as adjunctive therapy for patients with obsessive compulsive disorder (OCD) who have not adequately responded to first-line treatment with an approved OCD medication.
Researchers from the Department of Pulmonary Medicine and Sleep Disorders and All India Institute of Medical Sciences, New Delhi, India, studied the effects of yoga as a form of pulmonary rehabilitation on markers of inflammation in the body.
Every day, a school bus drops off as many as 45 children at a community eye clinic on Chicago's South Side. Many of them are referred to the clinic after failing vision screenings at their public schools.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Adetokunbo Olusola Ladipo, MD P.o. Box 1541, Anniston, AL 36202 Ph: (256) 236-3031 | Dr Adetokunbo Olusola Ladipo, MD 1306 Leighton Ave., Anniston, AL 36207 Ph: (256) 236-3031 |
News Archive
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that it has reached the enrollment goal of 325 patients for its Phase 2b dose-ranging clinical trial of XOMA 052, and that it expects patient enrollment to close in July 2010, with top-line results available in the first quarter of 2011. XOMA 052 is a therapeutic antibody candidate that inhibits the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) which drives the inflammatory cause of Type 2 diabetes.
Transcept Pharmaceuticals, Inc. today announced that it has completed enrollment in its Phase 2 clinical trial evaluating TO-2061 added as adjunctive therapy for patients with obsessive compulsive disorder (OCD) who have not adequately responded to first-line treatment with an approved OCD medication.
Researchers from the Department of Pulmonary Medicine and Sleep Disorders and All India Institute of Medical Sciences, New Delhi, India, studied the effects of yoga as a form of pulmonary rehabilitation on markers of inflammation in the body.
Every day, a school bus drops off as many as 45 children at a community eye clinic on Chicago's South Side. Many of them are referred to the clinic after failing vision screenings at their public schools.
› Verified 2 days ago
Dr. Rohit G Patel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 Keith Ave, Anniston, AL 36207 Phone: 256-236-8611 Fax: 256-236-8636 | |
Venugopala S Bheemanathini, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 522 E 11th St, Suite 200, Anniston, AL 36207 Phone: 256-237-5302 Fax: 256-237-5368 | |
Vishala Chindalore, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 Christine Ave, Anniston, AL 36207 Phone: 256-236-5631 Fax: 256-236-5637 | |
Dr. Chidiebere Maquincy Ibekwe, M.D, MPH, FACP Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 E 10th St, Anniston, AL 36207 Phone: 256-235-5639 | |
Wyndol Span Hamer Jr., M.D Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1700 Christine Ave, Suite 102, Anniston, AL 36207 Phone: 256-294-7004 Fax: 256-294-7005 | |
Almena Free, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 E 10th St, Anniston, AL 36207 Phone: 256-236-5631 Fax: 256-236-5335 | |
Mohamed Jasser, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 Leighton Ave, Suite 307, Anniston, AL 36207 Phone: 256-231-8636 Fax: 256-231-8684 |